Risk is part of our daily language and is used in a variety of contexts. Taking a risk is an option and not an unavoidable action. Risk management is increasingly becoming an essential part of processes also for pharmaceutical and biopharmaceutical sectors. The aim of this research was to evaluate the risks of prescribing by pharmacists compared to prescribing by medical practitioners taking antibiotics as a real case scenario. Interviews with industries extraneous to pharmacy were held to understand the meaning of risk in applied scenarios. Two self-administered questionnaires, one for medical practitioners (APQMedPract) and one for pharmacists (APQPharm) were developed and validated to establish pharmacist’s contribution in prescribing antibiotics. A regression model to statistically analyse and identify differences of risks involved when antibiotics are prescribed by the two healthcare professionals was developed. This research can help pharmacists identify risk scenarios in different pharmaceutical processes, rank and analyse the different risks, devise risk management plans and implement mitigation strategies to improve outcomes in various settings.
"Sinopsis" puede pertenecer a otra edición de este libro.
Risk is part of our daily language and is used in a variety of contexts. Taking a risk is an option and not an unavoidable action. Risk management is increasingly becoming an essential part of processes also for pharmaceutical and biopharmaceutical sectors. The aim of this research was to evaluate the risks of prescribing by pharmacists compared to prescribing by medical practitioners taking antibiotics as a real case scenario. Interviews with industries extraneous to pharmacy were held to understand the meaning of risk in applied scenarios. Two self-administered questionnaires, one for medical practitioners (APQMedPract) and one for pharmacists (APQPharm) were developed and validated to establish pharmacist’s contribution in prescribing antibiotics. A regression model to statistically analyse and identify differences of risks involved when antibiotics are prescribed by the two healthcare professionals was developed. This research can help pharmacists identify risk scenarios in different pharmaceutical processes, rank and analyse the different risks, devise risk management plans and implement mitigation strategies to improve outcomes in various settings.
The authors are members of the Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta. Maresca Attard Pizzuto successfully completed a PhD. Anthony Serracino-Inglott is professor of pharmacy. Professor Lilian M Azzopardi is Head of Department.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Risk is part of our daily language and is used in a variety of contexts. Taking a risk is an option and not an unavoidable action. Risk management is increasingly becoming an essential part of processes also for pharmaceutical and biopharmaceutical sectors. The aim of this research was to evaluate the risks of prescribing by pharmacists compared to prescribing by medical practitioners taking antibiotics as a real case scenario. Interviews with industries extraneous to pharmacy were held to understand the meaning of risk in applied scenarios. Two self-administered questionnaires, one for medical practitioners (APQMedPract) and one for pharmacists (APQPharm) were developed and validated to establish pharmacist's contribution in prescribing antibiotics. A regression model to statistically analyse and identify differences of risks involved when antibiotics are prescribed by the two healthcare professionals was developed. This research can help pharmacists identify risk scenarios in different pharmaceutical processes, rank and analyse the different risks, devise risk management plans and implement mitigation strategies to improve outcomes in various settings. 464 pp. Englisch. Nº de ref. del artículo: 9783659953316
Cantidad disponible: 2 disponibles
Librería: moluna, Greven, Alemania
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Attard Pizzuto MarescaThe authors are members of the Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta. Maresca Attard Pizzuto successfully completed a PhD. Anthony Serracino-Inglott is professor of pharmac. Nº de ref. del artículo: 158607006
Cantidad disponible: Más de 20 disponibles
Librería: preigu, Osnabrück, Alemania
Taschenbuch. Condición: Neu. Innovative Tools to Investigate Risk In Pharmaceutical Processes | Maresca Attard Pizzuto (u. a.) | Taschenbuch | 464 S. | Englisch | 2016 | LAP LAMBERT Academic Publishing | EAN 9783659953316 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Nº de ref. del artículo: 107548023
Cantidad disponible: 5 disponibles
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Risk is part of our daily language and is used in a variety of contexts. Taking a risk is an option and not an unavoidable action. Risk management is increasingly becoming an essential part of processes also for pharmaceutical and biopharmaceutical sectors. The aim of this research was to evaluate the risks of prescribing by pharmacists compared to prescribing by medical practitioners taking antibiotics as a real case scenario. Interviews with industries extraneous to pharmacy were held to understand the meaning of risk in applied scenarios. Two self-administered questionnaires, one for medical practitioners (APQMedPract) and one for pharmacists (APQPharm) were developed and validated to establish pharmacist¿s contribution in prescribing antibiotics. A regression model to statistically analyse and identify differences of risks involved when antibiotics are prescribed by the two healthcare professionals was developed. This research can help pharmacists identify risk scenarios in different pharmaceutical processes, rank and analyse the different risks, devise risk management plans and implement mitigation strategies to improve outcomes in various settings.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 464 pp. Englisch. Nº de ref. del artículo: 9783659953316
Cantidad disponible: 1 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Risk is part of our daily language and is used in a variety of contexts. Taking a risk is an option and not an unavoidable action. Risk management is increasingly becoming an essential part of processes also for pharmaceutical and biopharmaceutical sectors. The aim of this research was to evaluate the risks of prescribing by pharmacists compared to prescribing by medical practitioners taking antibiotics as a real case scenario. Interviews with industries extraneous to pharmacy were held to understand the meaning of risk in applied scenarios. Two self-administered questionnaires, one for medical practitioners (APQMedPract) and one for pharmacists (APQPharm) were developed and validated to establish pharmacist's contribution in prescribing antibiotics. A regression model to statistically analyse and identify differences of risks involved when antibiotics are prescribed by the two healthcare professionals was developed. This research can help pharmacists identify risk scenarios in different pharmaceutical processes, rank and analyse the different risks, devise risk management plans and implement mitigation strategies to improve outcomes in various settings. Nº de ref. del artículo: 9783659953316
Cantidad disponible: 1 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Paperback. Condición: Brand New. 464 pages. 8.66x5.91x1.05 inches. In Stock. Nº de ref. del artículo: 3659953318
Cantidad disponible: 1 disponibles